Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEISMIC Phase II trial of MyoCell in ischemic cardiomyopathy after myocardial infarction
ISRCTN17181395Phase 2Completed
- Sponsor
- Bioheart, Inc.
- Start
- Mar 2006
- Modality
- Stem Cell Therapies → Cell Therapies
01
Overview
Phase 2, randomised, open-label trial of MyoCell in ischaemic cardiomyopathy (ICM) and heart failure (HF) (2 arms), sponsored by Bioheart, Inc. Started Mar 2006; status: completed.
02
Drugs
MyoCell
03
Conditions
ischaemic cardiomyopathy (ICM)heart failure (HF)
Beyond the preview
Go deeper on ISRCTN17181395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17181395.